Agenus Ownership
| AGEN Stock | USD 1.73 0.05 2.81% |
Shares in Circulation | First Issued 2000-03-31 | Previous Quarter 21.1 M | Current Value 21.6 M | Avarage Shares Outstanding 4.3 M | Quarterly Volatility 5.6 M |
Agenus |
Agenus Stock Ownership Analysis
About 36.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 11.02. Agenus Inc last dividend was issued on the 29th of October 2010. The entity had 1:20 split on the 12th of April 2024. Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. Agenus Inc. was founded in 1994 and is headquartered in Lexington, Massachusetts. Agenus operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 441 people. For more info on Agenus Inc please contact Garo Armen at 781 674 4400 or go to https://www.agenusbio.com.Besides selling stocks to institutional investors, Agenus also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Agenus' stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Agenus' strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Agenus Quarterly Liabilities And Stockholders Equity |
|
Only 1.41% of Agenus Inc are currently held by insiders. Unlike Agenus' institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Agenus' private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Agenus' insider trades
Agenus Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Agenus is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Agenus Inc backward and forwards among themselves. Agenus' institutional investor refers to the entity that pools money to purchase Agenus' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Jane Street Group Llc | 2024-12-31 | 105.7 K | Federated Hermes Inc | 2024-12-31 | 99.8 K | Fmr Inc | 2024-12-31 | 91.6 K | Key Client Fiduciary Advisors, Llc | 2024-12-31 | 68.1 K | Deutsche Bank Ag | 2024-12-31 | 61.1 K | Bank Of New York Mellon Corp | 2024-12-31 | 54.7 K | Charles Schwab Investment Management Inc | 2024-12-31 | 48 K | Avestar Capital, Llc | 2024-12-31 | 41.5 K | Ovata Capital Management Ltd | 2024-12-31 | 40 K | Vanguard Group Inc | 2024-12-31 | 2.4 M | Blackrock Inc | 2024-12-31 | 1.6 M |
Agenus Inc Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Agenus insiders, such as employees or executives, is commonly permitted as long as it does not rely on Agenus' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Agenus insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Agenus Outstanding Bonds
Agenus issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Agenus Inc uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Agenus bonds can be classified according to their maturity, which is the date when Agenus Inc has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| ADVGRO 8625 30 SEP 27 Corp BondUS00840KAA79 | View | |
| US00842XAA72 Corp BondUS00842XAA72 | View | |
| US00846UAL52 Corp BondUS00846UAL52 | View | |
| AGILENT TECHNOLOGIES INC Corp BondUS00846UAK79 | View | |
| AGILENT TECHNOLOGIES INC Corp BondUS00846UAN19 | View | |
| Agilent Technologies 21 Corp BondUS00846UAM36 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Agenus Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Agenus. If investors know Agenus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Agenus listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (11.02) | Revenue Per Share | Quarterly Revenue Growth 0.033 | Return On Assets | Return On Equity |
The market value of Agenus Inc is measured differently than its book value, which is the value of Agenus that is recorded on the company's balance sheet. Investors also form their own opinion of Agenus' value that differs from its market value or its book value, called intrinsic value, which is Agenus' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Agenus' market value can be influenced by many factors that don't directly affect Agenus' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Agenus' value and its price as these two are different measures arrived at by different means. Investors typically determine if Agenus is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Agenus' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.